Videos

Jeffrey Weber, M.D., Ph.D., Deputy Director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses how important it is that patients speak up when they experience side effects from their cancer treatments.

Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.

Michael D. Becker, cancer survivor and author of “A Walk With Purpose: Memoir of a Bioentrepreneur” discusses how he realized that he had head and neck cancer.

Kathryn Burn, head of Partnerships and Research at Smart Patients, discusses her organization's role in the National Cancer Moonshot Initiative.

Andrea J. Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, offers advice for patients with liver cancer. Wilson started the foundation after her younger sister, Adrienne, died of liver cancer.

Researchers might be on to a new biomarker for patients with colorectal cancer, says Martin D. Berger, M.D., oncologist at the University of Southern California.

Gary A. Puckrein, Ph.D., president and CEO of the National Minority Quality Forum, says that cancer statistics are not the same across the nation.

Lauren Belive, Senior Federal Government Relations Manager at Lyft, discusses the company's Treatment Transport program.

Kathleen Gallagher, MPH, senior director of Health Services Research and Outcomes at the National Patient Advocate Foundation, discusses the importance of data sharing in advancing cancer care.

Beth Meagher, of Deloitte Consulting, discusses the importance of early cancer detection.

Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.

Patricia J. Goldsmith, CEO of CancerCare, discusses the importance of coordinating between health care professionals as a patient moves into survivorship and converts to treating cancer as a chronic illness.

Jeff Allen, president and CEO of Friends of Cancer Research, shares what he hopes continuing advancements and the Cancer Moonshot will achieve in cancer care.

Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Sidney Kimmel Cancer Center, discusses plans to maintain momentum on the Cancer Moonshot initiative.

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.

Syed Jafri, M.D., an assistant professor at the University of Texas McGovern School of Medicine, discusses the potential role that stress could play in lung cancer diagnoses.

Richard Boulay, M.D., chief of the division of Gynecologic Oncology at the Lehigh Valley Health Netowrk, tells the story of removing a 140-pound tumor from Mary Clancy. The tumor had been growing for at least 10 years when it was caught by a CAT scan, and was about half her body weight.

Jeffrey Holzbeierlein, M.D., University of Kansas Medical Center, discusses how important it was that a multidisciplinary team came together to create the non-metastatic muscle-invasive bladder cancer guidelines.

Jonathan E. Rosenberg, M.D., medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the new treatment guidelines for patients with non-metastatic muscle invasive bladder cancer.

NFL player and founder of the Chris Draft Family Foundation, Chris Draft, explains what caregivers need to know.

Ramy Ibrahim, M.D., vice president of Clinical Development at the Parker Institute for Cancer Immunotherapy discusses how the institute's mission aligns with the mission of the Cancer Moonshot.

Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.

Fay Hlubocky, Ph.D., M.A., University of Chicago Medicine, discusses the challenges that women with ovarian cancer face that may be different than those diagnosed with other cancers.

Greg Simon, CEO of the Biden Cancer Initiative, discusses the transition from the Cancer Moonshot Initiative to the Biden Cancer Initiative.